144 related articles for article (PubMed ID: 10671211)
1. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
Viemann D; Schlenke P; Hammers HJ; Kirchner H; Kruse A
Eur J Immunol; 2000 Feb; 30(2):550-9. PubMed ID: 10671211
[TBL] [Abstract][Full Text] [Related]
2. CD22 regulates thymus-independent responses and the lifespan of B cells.
Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
[TBL] [Abstract][Full Text] [Related]
3. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
Nadler MJ; McLean PA; Neel BG; Wortis HH
J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
[TBL] [Abstract][Full Text] [Related]
4. Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
Nitschke L; Tsubata T
Trends Immunol; 2004 Oct; 25(10):543-50. PubMed ID: 15364057
[TBL] [Abstract][Full Text] [Related]
5. Regulation of lymphocyte activation by the cell-surface molecule CD22.
Law CL; Sidorenko SP; Clark EA
Immunol Today; 1994 Sep; 15(9):442-9. PubMed ID: 7945784
[TBL] [Abstract][Full Text] [Related]
6. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
7. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
[TBL] [Abstract][Full Text] [Related]
8. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor.
Sato S; Tuscano JM; Inaoki M; Tedder TF
Semin Immunol; 1998 Aug; 10(4):287-97. PubMed ID: 9695185
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the expression and gene promoter of CD22 in murine B cells.
Andersson KB; Draves KE; Magaletti DM; Fujioka S; Holmes KL; Law CL; Clark EA
Eur J Immunol; 1996 Dec; 26(12):3170-8. PubMed ID: 8977319
[TBL] [Abstract][Full Text] [Related]
10. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
Chaouchi N; Vazquez A; Galanaud P; Leprince C
J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
[TBL] [Abstract][Full Text] [Related]
11. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
[TBL] [Abstract][Full Text] [Related]
12. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
13. Constitutive endocytosis and degradation of CD22 by human B cells.
Shan D; Press OW
J Immunol; 1995 May; 154(9):4466-75. PubMed ID: 7722303
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
15. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.
Campbell MA; Klinman NR
Eur J Immunol; 1995 Jun; 25(6):1573-9. PubMed ID: 7542197
[TBL] [Abstract][Full Text] [Related]
16. Intracellular CD22 rapidly moves to the cell surface in a tyrosine kinase-dependent manner following antigen receptor stimulation.
Sherbina NV; Linsley PS; Myrdal S; Grosmaire LS; Ledbetter JA; Schieven GL
J Immunol; 1996 Nov; 157(10):4390-8. PubMed ID: 8906814
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms regulating CD19, CD20 and CD22 gene expression.
Kehrl JH; Riva A; Wilson GL; Thévenin C
Immunol Today; 1994 Sep; 15(9):432-6. PubMed ID: 7524520
[TBL] [Abstract][Full Text] [Related]
18. Expansion of CD22lo B cells in the spleen of autoimmune-prone flaky skin mice.
Mattsson N; Duzevik EG; Pelsue SC
Cell Immunol; 2005 Apr; 234(2):124-32. PubMed ID: 16054613
[TBL] [Abstract][Full Text] [Related]
19. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
[TBL] [Abstract][Full Text] [Related]
20. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.
Stamenkovic I; Seed B
Nature; 1990 May; 345(6270):74-7. PubMed ID: 1691828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]